1995
DOI: 10.1097/00007890-199505000-00013
|View full text |Cite
|
Sign up to set email alerts
|

Enisoprost in Liver Transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

1998
1998
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…alprosand Treatment tadil) have been studied in both renal and liver transplant recipients. [30][31][32][33][34][35][36] In liver transplant patients treated with cyclosporine, There are a variety of approaches to treat the patient with drugalprostadil was studied versus placebo with no between-group induced early renal insufficiency. These may be divided into difference in the effect on serum creatinine levels.…”
Section: Muromonab Cd3mentioning
confidence: 99%
See 2 more Smart Citations
“…alprosand Treatment tadil) have been studied in both renal and liver transplant recipients. [30][31][32][33][34][35][36] In liver transplant patients treated with cyclosporine, There are a variety of approaches to treat the patient with drugalprostadil was studied versus placebo with no between-group induced early renal insufficiency. These may be divided into difference in the effect on serum creatinine levels.…”
Section: Muromonab Cd3mentioning
confidence: 99%
“…These may be divided into difference in the effect on serum creatinine levels. [32,35,37] calcineurin inhibitor-withdrawal, calcineurin inhibitor-modificaEnisoprost, a synthetic PGE methyl ester analog, also failed to tion strategies, as well as additive medicines, which act to reduce demonstrate benefit on renal function or the incidence of rejection renal impairment.…”
Section: Muromonab Cd3mentioning
confidence: 99%
See 1 more Smart Citation
“…Another randomized, prospective, multi‐center trial demonstrated improved renal function and decreased ICU stay, but no improvement in survival or rate of PNF (13). A randomized study in the UK failed to show any benefit of a PGE 1 infusion post‐operatively, in either renal function or incidence of PNF (14). A recent meta‐analysis that investigated the effect of PGE 1 on renal function in a very heterogeneous population showed no significant difference (15).…”
Section: Role Of Pge1 and Nac In Ischemia/reperfusion Injurymentioning
confidence: 99%